Iodoform-Calcium Hydroxide (Metapex)

PreclinicalSmall molecule

OOctober University for Modern Sciences and Arts

Iodoform-Calcium Hydroxide (Metapex) is one of 3 small molecule programs targeting Calcium Hydroxide. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Calcium HydroxideRecruiting

Calcium HydroxidePreclinical

Recruiting

Competition

Competitive Landscape

4 competitors in Calcium Hydroxide

#DrugCompanyPhaseTrials

Chitosan

UUniversity Hospital, Basel, Switzerland

Preclinical

1 2

Iodoform-Calcium Hydroxide (Metapex)

OOctober University for Modern Sciences and Arts

Preclinical

1 3

Nano Silver Fluoride

OOctober University for Modern Sciences and Arts

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Calcium Hydroxide1 trial

Evaluation of Zinc Oxide Eugenol and Iodoform-Calcium Hydroxide as Filling Materials in Primary Molar Root Canals Prepared by Rotary and Manual Files

Recruiting·OOctober University for Modern Sciences and Arts·N/A·NCT07395401·44 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Iodoform-Calcium Hydroxide (Metapex). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Iodoform-Calcium Hydroxide (Metapex) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Iodoform-Calcium Hydroxide (Metapex). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — October University for Modern Sciences and Arts company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: OOctober University for Modern Sciences and Arts

Iodoform-Calcium Hydroxide (Metapex)

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Calcium Hydroxide1 trial

References

Drug Info

Quick Facts

Related News